United States · FDA National Drug Code directory
Labetalol Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-702_536f68cd-92b7-9015-e063-6394a90a9838
- Product NDC
- 68001-702
- Form
- TABLET
- Composition / generic term
- Labetalol Hydrochloride
- Labeler
- BluePoint Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260604
- Source listing expiry
- 20271231
Source-listed ingredients
- LABETALOL HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68001-702-00) · 68001-702-00
- 500 TABLET in 1 BOTTLE (68001-702-03) · 68001-702-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →